Phase 3 clinical trial E1912 The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) today announced results from an extended follow-up analysis of patients in its randomized Phase 3 clinical trial, E1912. The results show...

Moderna has submitted a request to the Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for its COVID-19 vaccine, mRNA-1273, in children 6 months to under 6 years of age. The submission is based...

Combination-based antibiotic treatments are gaining increasing attention. Here, Lázár et al. systematically quantify Staphylococcus aureus survival under a range of antibiotic combinations, revealing that reciprocal...

The Medicines Company announced topline results from the pivotal phase 3 ORION-11 study that evaluated the efficacy and safety of inclisiran, an investigational twice-yearly cholesterol-lowering therapy. Inclisiran is a...